Robert Celt
New Member
Two years after Utah clinical trials began, researchers say pharmaceutical-grade cannabis is yielding promising results for epilepsy patients.
Trials for Epidolex, a liquid, purified form of cannabidiol (CBD) began in 2014, conducted by the University of Utah's Division of Pediatric Neurology, the Salt Lake Tribune reports.
"So it's gone from helping just the children and parents in the state of Utah to helping virtually thousands in 11 other states," said the House Bill 105's sponsor, Gage Froerer. House Bill 105 allowed Primary Children's Hospital to conduct the study of CBD.
Two years later, medical researchers cite a 40 percent decrease in frequency and severity of epileptic seizures in their early results.
These results from Primary Children's Hospital in hand, pharmaceutical companies will meet again with the Food and Drug Administration to discuss approval.
About 30 Utahns have participated in the trial, which focuses on young adults and children with epilepsy. Most families reported seizure relief after beginning the trial, with one participant reporting being completely seizure free after using Epidolex.
Right now, only CBD is legal, not THC, which is the agent in cannabis that causes a "high."
"Basically so there's not psychoactive properties," said Forerer. "And this may take a number of years before they do have access to the THC component of it."
Last February, legislators voted to renew HB 105 for an additional 5 years. They also lowered the level of CBD in treatments.
"So we dropped the CBD level down to more commonly accepted practices."
This summer, a task force will study where to go next with CBD and THC treatments.
"So that these people do have access to products that will be beneficial without causing any undue social impacts," Forerer said.
News Moderator: Robert Celt 420 MAGAZINE ®
Full Article: Research Says Medical Marijuana Showing Promising Results
Author: Lisa Nico
Contact: KUTV
Photo Credit: None found
Website: KUTV
Trials for Epidolex, a liquid, purified form of cannabidiol (CBD) began in 2014, conducted by the University of Utah's Division of Pediatric Neurology, the Salt Lake Tribune reports.
"So it's gone from helping just the children and parents in the state of Utah to helping virtually thousands in 11 other states," said the House Bill 105's sponsor, Gage Froerer. House Bill 105 allowed Primary Children's Hospital to conduct the study of CBD.
Two years later, medical researchers cite a 40 percent decrease in frequency and severity of epileptic seizures in their early results.
These results from Primary Children's Hospital in hand, pharmaceutical companies will meet again with the Food and Drug Administration to discuss approval.
About 30 Utahns have participated in the trial, which focuses on young adults and children with epilepsy. Most families reported seizure relief after beginning the trial, with one participant reporting being completely seizure free after using Epidolex.
Right now, only CBD is legal, not THC, which is the agent in cannabis that causes a "high."
"Basically so there's not psychoactive properties," said Forerer. "And this may take a number of years before they do have access to the THC component of it."
Last February, legislators voted to renew HB 105 for an additional 5 years. They also lowered the level of CBD in treatments.
"So we dropped the CBD level down to more commonly accepted practices."
This summer, a task force will study where to go next with CBD and THC treatments.
"So that these people do have access to products that will be beneficial without causing any undue social impacts," Forerer said.
News Moderator: Robert Celt 420 MAGAZINE ®
Full Article: Research Says Medical Marijuana Showing Promising Results
Author: Lisa Nico
Contact: KUTV
Photo Credit: None found
Website: KUTV
